Clinical Trial Update: Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating maintenance tocolysis for threatened preterm delivery was withdrawn. No results were released.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Preterm Delivery. | Phase 3 | Status: WITHDRAWN